2.7. Outcome Assessment
pain
The primary outcome assessed was the comparative efficacy of two LAA, Lidocaine and Articaine, during II and ACP. The effectiveness of LA was described as a value of <54 mm on HP-VAS (No pain: 0 mm.Mild pain: between 0 and 54 mm.Moderate pain: between 54 and 114 mm.Severe pain: ≥114 mm.The HP-VAS, through its clear categories and descriptive language, facilitates accurate pain level assessment. 